Search results
Johnson & Johnson submits BLA to FDA for lung cancer drug
Pharmaceutical Technology via Yahoo Finance· 1 day agoJohnson & Johnson has filed a biologics licence application (BLA) with the US Food and Drug...
Breakthrough UC San Diego Brain Recording Device R | Newswise
Newswise· 14 hours agoThe Federal Drug Administration approved a clinical trial to test the effectiveness of an electronic...
Day One inks $1.2B biobucks pact for MabCare’s solid tumor ADC
FierceBiotech· 1 day agoDay One Biopharmaceuticals is offering MabCare Therapeutics up to $1.2 billion for exclusive licensing rights to an antibody drug conjugate (ADC) taking aim at solid tumors ...
MD Anderson Research Highlights for June 19, 2024 | Newswise
Newswise· 14 hours agoRecent developments at MD Anderson include resources to reconstruct tumor evolution using crowd-sourced algorithms, using lower doses of radiation to avoid toxicities in patients ...
Hyperbaric oxygen enhances tumor penetration and accumulation of engineered bacteria for synergistic...
Nature· 3 days agoDelivering bacteria-based drug for cancer therapy is limited by their penetration into extracellular matrix (ECM). Here the authors report effective depletion of ECM with ...
Implantable drug eluting devices: Key applications for silicone
Medical Device Network via Yahoo Finance· 1 day agoGrowing use of drug eluting implant devices can be linked directly to key advantages such as...
FDA grants approval for Bristol Myers Squibb’s Augtyro for solid tumours
Pharmaceutical Technology via Yahoo Finance· 3 days agoThe US Food and Drug Administration (FDA) has granted accelerated approval for Bristol Myers...
Radioactive drugs strike cancer with precision
Knowable Magazine via Yahoo News· 7 days agoThis surge in interest, he points out, underscores a wider recognition that radiopharmaceuticals offer “a fundamentally different...radioactivity decays....
...Health Strengthens Global Brain Tumor Market Position by Entering ...Rights to WIPO-Filed CNS...
Digital Journal· 1 day agoCHICAGO, IL / ACCESSWIRE / June 18, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative ...
Psoriatic Arthritis Drugs Comparably Improve Joint Outcomes
Medscape· 14 hours agoReal-world study data suggest there is little difference among five drug classes commonly used to treat PsA in terms of their ability to improve both joint and skin symptoms.